183490Enzychem Lifesciences Corporation183490 info
$1.14info1.27%24h
Global rank33055
Market cap$8.95M
Change 7d5.14%
YTD Performance-16.67%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Business data

    Enzychem Lifesciences Corporation (183490) Stock Overview

    Enzychem Lifesciences Corporation, a pharmaceutical company, focuses on the development of oral small molecule therapies for patients with unmet medical needs for oncology, metabolic diseases, and inflammatory diseases in South Korea. It is also developing potential therapies based on EC-18 technology platform to treat chemotherapy-induced neutropenia, chemoradiation therapy-induced oral mucositis, and acute radiation syndrome. The company was founded in 1999 and is headquartered in Seoul, South Korea.

    183490 Stock Information

    Symbol
    183490
    Address
    aT CenterSeoul, South Korea
    Founded
    -
    Trading hours
    -
    Website
    https://www.enzychem.com
    Country
    🇰🇷 South Korea
    Phone Number
    82 1 201 321 6976

    Enzychem Lifesciences Corporation (183490) Price Chart

    -
    Value:-

    Enzychem Lifesciences Corporation Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $1.14
    N/A
    Market Cap
    $8.95M
    N/A
    Shares Outstanding
    7.84M
    N/A
    Employees
    113.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org